Prostate-Specific Antigen: Improving Its Ability to Diagnose Early Prostate Cancer

JAMA: The Journal of the American Medical Association

Volumn 267, Issue 16, 1992, Pages 2236-2238

  Oesterling, Joseph E ^a  

^a DEPARTMENT OF UROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BLOOD LEVEL; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; ECHOGRAPHY; EDITORIAL; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATITIS;

ANTIGENS, NEOPLASM; HUMAN; MALE; MASS SCREENING; MIDDLE AGE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0026519302     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03480160094042     Document Type: Article

References (19)

1. Hara M, Koyanagi Y, Inoue T, et al. Some physico-chemical characteristics of gamma-seminoprotein,’ an antigenic component specific for human seminal plasma: forensic immunological study of body fluids and secretion, VII [in Japanese]. Nippon Hoigaku Zasshi. 1971;25:322-324.
2. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol. 1979;17:159-163.
3. Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM. The palpable nodule of prostatic cancer: results 15 years after radical excision. JAMA. 1968;203:403-406.
4. Johansson J-E, Adami HO, Andersson S-O, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992;267:2191-2196.
5. Whitmore WF Jr, Warner JA, Thompson IM Jr. Expectant management of localized prostatic cancer. Cancer. 1991;67:1091-1096.
6. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage Al prostatic carcinoma: a study of 94 cases with extended follow up. J Urol. 1986;136:837-839.
7. American Cancer Society. Cancer Facts and Figures, 1992. Atlanta: Ga: American Cancer Society; 1992.
8. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.
9. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vesselia RL, Lange PH. Screening for prostatic carcinoma with prostate-specific antigen. J Urol. 1992;147:841-845.
10. Cupp MR, Oesterling JE. DRE, PSA, and TRUS: a proposal for their efficient use in early detection of clinically significant prostate cancer. AUA Today. 1992;5:1-9.
11. Cooner WH, Mosley RB, Rutherford CL Jr, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990;143:1146-1152.
12. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907-923.
13. Oesterling JE, Chan DW, Epstein JI, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988;139:766-772.
14. Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostatespecific antigen levels in men with and without prostate disease. JAMA. 1992;267:2215-2220.
15. Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. The influence of reversible androgen deprivation on serum prostate specific antigen levels in men with benign prostatic hyperplasia. J Urol. 1989;141:987-992.
16. Benson MC, Whang IS, Pantuck A, et al. Prostate-specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147:815-816.
17. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate-specific antigen density to enhance the predictive value of intermediate levels of serum prostate-specific antigen. J Urol. 1992;147:817-821.
18. Crawford ED, Schutz MJ, Clejan S, et al. The effect of digital rectal examination on prostate-specific antigen levels. JAMA. 1992;267:2227-2228.
19. Chybowski FM, Bergstralh EJ, Oesterling JE. The effect of digital rectal examination on the serum prostate-specific antigen concentration: results of a prospective, randomized controlled study. J Urol. In press.